Caricamento...

Inhibition of N-Linked Glycosylation Disrupts Receptor Tyrosine Kinase Signaling in Tumor Cells

Receptor tyrosine kinases (RTK) are therapeutic targets for the treatment of malignancy. However, tumor cells develop resistance to targeted therapies through the activation of parallel signaling cascades. Recent evidence has shown that redundant or compensatory survival signals responsible for resi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Contessa, Joseph N., Bhojani, Mahaveer S., Freeze, Hudson H., Rehemtulla, Alnawaz, Lawrence, Theodore S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3696581/
https://ncbi.nlm.nih.gov/pubmed/18483264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-07-6389
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !